US20020050661A1 - A method of making an expandable fluoropolymer device - Google Patents
A method of making an expandable fluoropolymer device Download PDFInfo
- Publication number
- US20020050661A1 US20020050661A1 US09/410,329 US41032999A US2002050661A1 US 20020050661 A1 US20020050661 A1 US 20020050661A1 US 41032999 A US41032999 A US 41032999A US 2002050661 A1 US2002050661 A1 US 2002050661A1
- Authority
- US
- United States
- Prior art keywords
- tube
- diameter
- balloon
- radially
- expanded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C55/00—Shaping by stretching, e.g. drawing through a die; Apparatus therefor
- B29C55/22—Shaping by stretching, e.g. drawing through a die; Apparatus therefor of tubes
- B29C55/24—Shaping by stretching, e.g. drawing through a die; Apparatus therefor of tubes radial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/041—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
- B29C48/09—Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
- B29C48/09—Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
- B29C48/10—Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels flexible, e.g. blown foils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C49/00—Blow-moulding, i.e. blowing a preform or parison to a desired shape within a mould; Apparatus therefor
- B29C49/42—Component parts, details or accessories; Auxiliary operations
- B29C49/46—Component parts, details or accessories; Auxiliary operations characterised by using particular environment or blow fluids other than air
- B29C2049/4602—Blowing fluids
- B29C2049/465—Blowing fluids being incompressible
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2027/00—Use of polyvinylhalogenides or derivatives thereof as moulding material
- B29K2027/12—Use of polyvinylhalogenides or derivatives thereof as moulding material containing fluorine
- B29K2027/18—PTFE, i.e. polytetrafluorethene, e.g. ePTFE, i.e. expanded polytetrafluorethene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2022/00—Hollow articles
- B29L2022/02—Inflatable articles
- B29L2022/022—Balloons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2305/00—Condition, form or state of the layers or laminate
- B32B2305/02—Cellular or porous
- B32B2305/026—Porous
Definitions
- Radially expandable devices are utilized in a wide range of applications including a number of biological applications. Radially expandable devices in the form of inflatable balloons have been proposed for treatment of body passages occluded by disease and for maintenance of the proper position of catheter delivered medical devices within such body passages. Such expandable devices can be constructed of elastomeric materials such as latex. A number of general problems are associated with such elastomeric balloons. Balloons and other expansion devices constructed of elastomeric materials can lack a maximum inflation or expansion diameter in that the prolonged application of an inflation medium will cause the balloon to continuously expand until the balloon bursts. Thus, over inflation of an elastomeric balloon may result in damage to the body vessel or organ being treated or may result in the balloon bursting within the body.
- Elastomeric balloons frequently do not inflate symmetrically and may not inflate to the desired size and shape. Asymmetrical expansion, as well as failure of the balloon to properly inflate, can lead to incomplete treatment of the body vessel. The high coefficient of friction of most elastomeric materials, such as latex, can result in damage to one or more cellular layers of the wall of the body vessel or organ being treated. Additionally, elastomeric expansion devices generally have insufficient strength for a number of applications, such as compressing deposits formed on vascular walls and positioning catheter delivered medical devices.
- the present invention provides a radially expandable device having a body constructed a fluoropolymer material, such as expanded polytetrafluoroethylene (ePTFE).
- ePTFE expanded polytetrafluoroethylene
- the use of fluoropolymer materials provides a radial expandable device having a biocompatible and inelastic construction that is suitable for numerous uses including the treatment of body vessels, organs, and implanted grafts.
- the body of the radially expandable device has a longitudinal axis and a wall having a thickness transverse to the longitudinal axis.
- the wall of the body is characterized by a microstructure of nodes interconnected by fibrils.
- the body of the radially expandable device is deployable from a reduced diameter, collapsed configuration to an increased diameter, expanded configuration upon application of an expansion force to the radially expandable device.
- substantially all the nodes of the microstructure are oriented generally perpendicularly to the longitudinal axis of the body. This orientation of the nodes, perpendicular to the longitudinal axis of the body, yields a radially expandable device that predictably and dependably expands to the increased diameter configuration.
- the body of the radially expandable device has a monolithic construction.
- the monolithic body of the radially expandable device of the present invention is characterized by a seamless construction of fluoropolymer material, such as expanded polytetrafluoroethylene (ePTFE), preferably constructed through an extrusion and expansion process. Because the cross section of the monolithic body is singular or unitary, the expandable device lacks seams or internal interfaces between adjacent layers that can result in unreliable expansion of the device.
- the monolithic construction of the body of the present invention contributes to the dependable and predictable expansion of the body to a predefined, fixed maximum diameter that is generally independent of the expansion force used to radially expand the device.
- a method for manufacturing a radially expandable device constructed of a fluoropolymer material such as, for example, ePTFE.
- the method includes the step of forming a tube of fluoropolymer material having an initial diameter.
- a radial expansion force is applied to the tube to expand the tube from the initial diameter to a second diameter.
- the expansion force is then removed.
- the resultant tube is radially expandable from a reduced diameter to the second diameter upon application of a radial deployment force from a deployment mechanism within the tube.
- the deployment mechanism can be, for example, a fluid injected into the tube or a radial expansion element inserted into the tube.
- a radially expandable device constructed in accordance with the method of the present invention can be dependably and predictably expanded to the second diameter upon the application of a radially deployment force within the tube.
- the second diameter can be predefined and fixed to a maximum expansion diameter through the manufacturing process of the present invention, resulting in an expansion device having a maximum expansion diameter that is generally independent of the radial deployment force applied to the device.
- the fluoropolymer tube can be constructed through an extrusion and expansion process including the step of creating a billet by blending a mixture of a fluoropolymer and a lubricant and compressing the mixture.
- the fluoropolymer is preferably PTFE.
- the billet can then be extruded to form an extruded article.
- the lubricant is removed and the extruded article is expanded to form a monolithic tube of inelastic, expanded fluoropolymer material.
- the stretched tube is then heat set to lock in the microstructure of the tube and maintain the tube in the stretched state.
- the extruded article is preferably bilaterally stretched in two opposing directions along the longitudinal axis of the article. Bilaterally stretching the extruded article yields an article that is substantially uniformly stretched over a major portion of its length and has a microstructure of nodes interconnected by fibrils.
- the bilateral stretching step can be carried out by displacing the ends of the extruded article either simultaneously or sequentially.
- the longitudinal stretch ratio of the expanded tube i.e., the ratio of the final stretched length of the tube to the initial length
- the diametric stretch ratio i.e., the ratio of the final diameter, after longitudinal stretching, and the initial diameter, can be varied to yield an expansion device having differing radial expansion properties.
- the magnitude of the deployment force necessary to expand the expansion device of the present invention can be pre-selected and manipulated by varying the stretch ratios of the fluoropolymer tube. Additionally, the stretch rate can be varied to selectively provide the expansion device with improved expansion characteristics.
- the step of applying a radial expansion force to the fluoropolymer tube is carried out by inserting a balloon into the tube and expanding the balloon to apply the radial expansion force to the tube.
- the balloon is constructed from an inelastic material such as, for example, polyethylene terephthalate (PET) or nylon.
- PET polyethylene terephthalate
- the balloon is constructed to be expandable to a predefined size and shape by inflation with a fluid. Radial expansion of the fluoropolymer tube with such an inelastic balloon imparts the predetermined size and shape of the balloon to the expanded fluoropolymer balloon.
- the step of radially expanding the fluoropolymer tube plastically deforms the tube beyond its elastic limit to the second diameter.
- Plastically deforming the fluoropolymer tube to the second diameter contributes to expansion device dependably expanding to the second diameter upon application of the radial deployment force.
- the step of radially expanding the fluoropolymer tube can also include the steps of positioning the tube within the internal cavity of a mold fixture and radially expanding the balloon within the tube while the tube remains positioned in the internal mold cavity.
- the internal mold cavity preferably has a size and shape analogous to the predefined size and shape of the balloon.
- the internal cavity of the mold facilitates concentric radial expansion of the balloon and the fluoropolymer tube.
- the step of applying a radial expansion force to the fluoropolymer tube is carried out by inserting a second tube constructed from an extruded inelastic material, such as extruded PET, into the fluoropolymer tube and expanding the second tube to apply the radial expansion force to the tube.
- a second tube constructed from an extruded inelastic material, such as extruded PET
- the fluoropolymer tube and the second tube are heated to a temperature less than or equal to the glass transition temperature of the extruded material forming the second tube during the radial expansion step.
- the heating of the tubes can be accomplished by submerging the tubes into a hot water bath.
- the fluoropolymer tube can be expanded by the second tube within a heated mold.
- the radially expandable device of the present invention is particularly suited for treatment of body passages occluded by disease.
- the expandable device can be utilized in the manner of a catheter balloon suitable for deployment within a body vessel by a catheter.
- Exemplary treatment applications of the present application include dilation of stenoic blood vessels in a percutaneous transluminal angioplasty procedure (PTA), removal of thrombi and emboli from obstructed blood vessels, urethra dilation to treat prostatic enlargement due to benign prostate hyperplasia (BPH) or prostatic cancer, and generally restoring patency to implanted grafts or body passages such as blood vessels, the urinary tract, the intestinal tract, the kidney ducts, or other body passages.
- PTA percutaneous transluminal angioplasty procedure
- BPH benign prostate hyperplasia
- prostatic cancer prostatic cancer
- FIG. 1 is a side elevational view in cross-section of a radially expandable device according to the teachings of the present invention, illustrating the device in a first, reduced diameter configuration;
- FIG. 2 is a side elevational view in cross-section of the radially expandable device of FIG. 1, illustrating the device in a second, increased diameter configuration;
- FIG. 3 is a schematic representation of the microstructure of a section of the wall of an expanded fluoropolymer tube used during the manufacturing process of the present invention to yield the radially expandable device of the present invention
- FIG. 4A is a side elevational view in cross-section of an inelastic balloon positioned within an expanded fluoropolymer tube, illustrating the inelastic balloon in a deflated condition in accordance with a method of manufacturing a radially expandable device according to the teachings of the present invention
- FIG. 4B is a side elevational view in cross-section of the inelastic balloon and the expanded fluoropolymer tube of FIG. 4A, illustrating the inelastic balloon in an inflated condition in accordance with a method of manufacturing a radially expandable device according to the teachings of the present invention
- FIG. 4C is a side elevational view in cross-section of the inelastic balloon and the expanded fluoropolymer tube of FIG. 4A, illustrating the removal of the deflated inelastic balloon from the expanded fluoropolymer tube in accordance with a method of manufacturing a radially expandable device according to the teachings of the present invention
- FIG. 5 is a side elevational view of an inelastic balloon and an expanded fluoropolymer tube positioned within the internal cavity of a mold fixture, illustrating the inelastic balloon in a inflated condition in accordance with a method of manufacturing a radially expandable device according to the teachings of the present invention
- FIG. 6A is a flow chart illustrating the steps of manufacturing a radially expandable device according to the teachings of the present invention.
- FIG. 6B is a flow chart illustrating the steps of an alternative method of manufacturing a radially expandable device according to the teachings of the present invention.
- FIG. 7A is a side elevational view in cross section of a generally pear-shaped radially expandable device in accordance with the teaching of the present invention.
- FIG. 7B is a side elevational view in cross section of a generally hour glass shaped radially expandable device in accordance with the teaching of the present invention.
- FIG. 7C is a side elevational view in cross section of two coaxially aligned, adjacent radially expandable devices in accordance with the teaching of the present invention.
- FIG. 8 is a side elevational view in cross section of a catheter deployed dilation balloon according to the teaching of the present invention, illustrating the dilation balloon expanded within a body vessel.
- FIGS. 1 and 2 A radially expandable device 10 having a body 12 constructed of a generally inelastic, expanded fluoropolymer material is illustrated in FIGS. 1 and 2.
- Expandable devices provided by the present invention are suitable for a wide range of applications including, for example, a range of medical treatment applications.
- Exemplary biological applications include use as a catheter balloon for treatment of implanted grafts and body passages such as blood vessels, the urinary tract, the intestinal tract, kidney ducts, etc.
- the expandable device of the present invention can also be used as a sheath for covering conventional catheter balloons to control the expansion of the conventional balloon.
- the body 12 of the radially expandable device 10 is deployable upon application of an expansion force from a first, reduced diameter configuration, illustrated in FIG. 1, to a second, increased diameter configuration, illustrated in FIG. 2.
- the body 12 of the expansion device 10 of the present invention preferably features a monolithic construction, i.e., the body 12 is a singular, unitary article of generally homogeneous material.
- the body 12 is manufactured in accordance with the methods of manufacturing of the present invention, an extrusion and expansion process described in detail below, to yield a body 12 characterized by a seamless construction of inelastic, expanded fluoropolymer having a predefined size and shape in the second, increased diameter configuration.
- the body 12 can be dependably and predictably expanded to the predefined, fixed maximum diameter and to the predefined shape independent of the expansion force used to expand the device.
- the body 12 of the radial expansion device 10 of the present invention is preferably generally tubular in shape when expanded, although other cross sections, such as rectangular, oval, elliptical, or polygonal, can be utilized.
- the cross section of the body 12 is preferably continuous and uniform along the length of the body. However, in alternative embodiments, the cross section can vary in size and/or shape along the length of the body.
- FIG. 1 illustrates the body 12 relaxed in the first, reduced diameter configuration.
- the body 12 has a central lumen 13 extending along a longitudinal axis 14 between a first end 16 and second end 18 .
- a deployment mechanism in the form of an elongated hollow tube 20 is shown positioned within the central lumen 13 to provide a radial deployment or expansion force to the body 12 .
- the radial deployment force effects radial expansion of the body 12 from the first configuration to the second increased diameter configuration illustrated in FIG. 2.
- the first end 16 and the second end 18 are connected in sealing relationship to the outer surface of the hollow tube 20 .
- the first and second ends 16 and 18 can be thermally bonded, bonded by means of an adhesive, or attached by other means suitable for inhibiting fluid leakage from the first and second ends 16 and 18 between the walls of the body 12 and the tube 20 .
- the hollow tube 20 includes an internal, longitudinal extending lumen 22 and a number of side-holes 24 that provide for fluid communication between the exterior of the tube 20 and the lumen 22 .
- the tube 20 can be coupled to a fluid source (not shown) to selectively provide fluid, such as water, saline, or air, to the lumen 13 of the body 12 through the lumen 22 and side-holes 24 .
- the pressure from the fluid provides a radial expansion force on the body 12 to radial expand the body 12 to the second, increased diameter configuration.
- the body 12 is constructed from an inelastic material, uncoupling the tube 20 from the fluid source or otherwise substantially reducing the fluid pressure within the lumen 13 of the body 12 , does not generally result in the body 12 returning to the first, reduced diameter configuration. However, the body 12 will collapse under its own weight to a reduced diameter.
- Application of negative pressure, from, for example, a vacuum source, can be used to completely deflate the body 12 to the initial reduced diameter configuration.
- expansion device 10 of the present invention is not limited to use with deployment mechanisms employing a fluid deployment force, such as hollow tube 20 .
- Other known deployment mechanisms can be used to radially deploy the expansion device 10 including, for example, mechanical operated expansion elements, such as mechanically activated members or mechanical elements constructed from temperature activated materials such as nitinol.
- Suitable fluoropolymer materials include, for example, polytetrafluoroethylene (PTFE) or copolymers of tetrafluoroethylene with other monomers may be used. Such monomers include ethylene, chlorotrifluoroethylene, perfluoroalkoxytetrafluoroethylene, or fluorinated propylenes such as hexafluoropropylene.
- PTFE is the preferred material of choice. Accordingly, while the radial expansion device 10 can be manufactured from various fluoropolymer materials, and the manufacturing methods of the present invention can utilize various fluoropolymer materials, the description set forth herein refers specifically to PTFE.
- the radially expandable device 10 of the present invention is produced from a tube 110 constructed of expanded fluoropolymer material, which is preferably produced through an extrusion and a longitudinal expansion process.
- the preferred fluoropolymer material is expanded PTFE (ePTFE), which is a hydrophobic, biocompatible, inelastic material having a low coefficient of friction, although, as discussed above, other inelastic, biocompatible fluoropolymer materials may be used.
- a billet comprising a PTFE resin mixed with an organic lubricant is utilized.
- organic lubricants are suitable such as naphtha, ISOPAR-G and ISOPAR-H available from Exxon Corporation.
- the blended resin is compressed at low pressure to yield a tubular billet of PTFE resin and lubricant, step 210 of FIG. 6A.
- the tubular billet is then extruded through an extruder, for example a ram extruder, to reduce the cross section of the billet and to yield a tubular extrudate, step 212 .
- the organic lubricant can be removed from the extrudate by drying the extrudate in a heated oven, step 214 .
- the extrudate is expanded by longitudinal stretching, step 216 .
- the extrudate is bilaterally stretched. Bilateral stretching is accomplished by displacing both ends of the extrudate, sequentially or simultaneously, away from the center of the extrudate. Bilateral stretching provides a material that is homogeneously stretched over the majority of its length. After the extrudate has been stretched, it is heat set to lock in the microstructure of the material, step 218 of FIG. 6A, and to complete the process of the forming the tube 110 of ePTFE.
- FIG. 3 is a schematic representation of the microstructure of the walls of the ePTFE tube 110 as formed by the extrusion and expansion process described above.
- the microstructure of the tube 110 has been exaggerated. Accordingly, while the dimensions of the microstructure are enlarged, the general character of the illustrated microstructure is representative of the microstructure prevailing within the tube 110 .
- the microstructure of the ePTFE tube 110 is characterized by nodes 130 interconnected by fibrils 132 .
- the nodes 130 are generally oriented perpendicular to the longitudinal axis 114 of the tube 110 .
- This microstructure of nodes 130 interconnected by fibrils 132 provides a microporous structure having microfibrillar spaces which define through-pores or channels 134 extending entirely from the inner wall 136 and the outer wall 138 of the tube 110 .
- the through-pores 134 are perpendicularly oriented (relative to the longitudinal axis 114 ), internodal spaces that traverse from the inner wall 136 to the outer wall 138 .
- the size and geometry of the through- pores 134 can be altered through the extrusion and stretching process, as described in detail in Applicants' copending U.S. patent application Ser. No. ______ (Attorney Docket No. ATA-257), filed on the same date as the present application, which is incorporated herein by reference, to yield a microstructure that is impermeable, semi-impermeable, or permeable.
- the ePTFE tube 110 and the resultant expandable device 10 , has a fine nodal structure that is uniform throughout the cross section and length of the ePTFE tube.
- the preferred uniform fine nodal structure provides the expandable device 10 with improved expansion characteristics as the expandable device dependably and predictably expands to the second diameter.
- the preferred fine nodal structure is characterized by nodes having a size and mass less than the nodes found in conventional ePTFE grafts, preferably in the range of 25 ⁇ m-30 ⁇ m.
- the spacing between the nodes referred to as the internodal distance
- the spacing between the fibers referred to as the interfibril distance
- the internodal distance and the interfibril distance in the preferred embodiment is preferably uniform throughout the length and the cross section of the ePTFE tube.
- the preferred uniform nodal structure can be created by forming the billet with a uniform lubricant level throughout its cross section and length. Stretching the tubular extrudate at higher stretch rates, for example at rates greater than 1 in/s, yields the preferred fine nodal structure. Preferably, the extrudate is stretched at a rate of approximately 10 in/s or greater.
- the ePTFE tube 110 is pulled over a balloon 112 to position the balloon 112 within the lumen 114 of the tube 110 , step 220 of FIG. 6A.
- the balloon 112 is preferably constructed of an inelastic material such as, for example, PET or nylon, such that the balloon 112 , when inflated, attains a predetermined size and shape.
- the balloon 112 can be bonded or otherwise coupled to a rigid catheter or hypo-tube 116 to facilitate placement and removal of the ePTFE tube as described below.
- the catheter 116 has a central inflation lumen 118 and a plurality of side-holes 120 to provide for the delivery of an inflation fluid to inflate the balloon 112 .
- the balloon 112 can be inflated by introduction of a pressurized fluid to the lumen 114 of the ePTFE tube 110 .
- the overlying ePTFE tube 110 expands with the inelastic balloon 122 until both the balloon 112 and the ePTFE tube 110 obtain the predetermined size and shape of the inflated balloon 112 , step 222 of FIG. 6A.
- the inflated balloon 112 thus imparts its predetermined size and shape to the ePTFE tube 110 .
- This radially expansion process is referred to as blow-molding.
- the PTFE tube 110 shown in FIG. 4B is radially expanded from the initial diameter d (FIG. 4A) to an increased diameter D.
- This radial expansion process may take place in an air, water, or steam-heated chamber that is heated to a temperature between 35° C. and 60° C., preferably 50° C.
- the elevated temperature can contribute to uniform expansion, both circumferentially and longitudinally, of the ePTFE balloon, as well as uniform wall thickness.
- the ePTFE tube 110 prefferably be plastically deformed by the radial expansion of the inelastic balloon 112 , step 222 of FIG. 6A.
- the terms “plastic deformation” and “plastically deform,” as used herein, is intended to include the radial expansion of the ePTFE tube 110 beyond the elastic limit of the ePTFE material such that the ePTFE material is permanently deformed.
- the ePTFE material forming the tube 110 becomes substantially inelastic, i.e., the ePTFE tube generally will not, on its own, return to its pre-expansion size and shape.
- the ePTFE tube 110 can be removed from the balloon 112 by sliding the ePTFE tube 110 relative to balloon 112 and catheter 116 , i.e. in the direction of arrows A in FIG. 4C, step 224 of FIG. 6A.
- the tube 110 can be heat set at a temperature above the sinter point of the material forming the tube, 360° C. for ePTFE, to lock in the structure of the tube 110 , step 225 of FIG. 6A.
- the resultant radially expanded ePTFE tube 110 provides a radially expandable device, such as expandable device 10 illustrated in FIGS. 1 and 2 and described above, that is radially expandable from a relaxed, collapsed diameter to the second, increased diameter D upon application of a radial deployment force from a deployment mechanism, e.g., hollow tube 20 , within the tube 110 .
- the ePTFE tube 110 further provides an expansion device 10 having monolithic construction, that is, a singular, unitary construction of generally homogenous material, ePTFE, that lacks seams or other internal interfaces.
- the ePTFE tube 110 can be dependably and predictably expanded to the second diameter D upon the application of the radially deployment force within the tube.
- the plastically deformed, monolithic microstructure of the ePTFE tube 110 once radially expanded by the inelastic balloon 120 , will readily return to the increased diameter D upon application of a radial deployment force and generally will not expand beyond the increased diameter D.
- the increased diameter D is effectively the maximum expansion diameter for the ePTFE tube, as the increased diameter D is generally independent of the radial deployment force applied to the tube.
- the mold 202 includes two interconnected sections 204 and 206 forming an internal mold cavity 208 for receiving the ePTFE tube 110 with the balloon 112 positioned therein.
- the mold 202 is preferably constructed of a rigid, unyielding material such as a metal or metal alloy. Suitable metals or metal alloys include brass and steel alloys.
- the internal mold cavity 208 preferably has a size and shape analogous to that of the inflated balloon 112 to ensure that the inflated balloon 112 , and the overlying ePTFE tube 110 concentrically expand.
- a tube constructed of ePTFE is formed in accordance with the methods described above, step 410 .
- a tube formed of an extruded inelastic material such as PET is used in place of balloon 112 to radially expand the ePTFE tube.
- the extruded tube is positioned within the ePTFE tube 110 , step 412 .
- the extruded tube is then sealed at one end and attached to an inflation system at the other end, step 414 .
- the extruded tube can then be inflated by an inflation medium to radially expand the ePTFE tube, step 416 .
- the extruded tube and ePTFE tube are preferably heated to the glass transition temperature of the extruded tube, approximately 80° C.-100° C. for PET, as the extruded tube is inflated within the ePTFE tube. It is preferable to limit the temperature of the extruded tube to a temperature less than or equal to the glass transition temperature of the material forming the extruded tube to facilitate removal of the extruded tube from the ePTFE tube. Heating the extruded tube to a temperature above the glass transition temperature will cause the extruded tube to heat set in an expanded configuration, which makes removing the extruded tube from the ePTFE tube difficult.
- the extruded tube and ePTFE tube are expanded to desired size and shape, the extruded tube is deflated and removed from the ePTFE tube, step 418 .
- the ePTFE tube is then heat set to lock in the structure of the ePTFE tube, step 420 .
- a mold such as mold 202
- the mold is preferably heated within the hot water chamber of the inflation system or by other means such as a hot oil bath or through a steam, hot air, electric, radio frequency or infra red heat source.
- the mold can be constructed of a material having good heat transfer characteristics, such as metal or metal alloy, for example brass.
- the mold includes a mold cavity having a size and shape analogous to the desired size and shape of the radially expandable device 10 in the second diameter configuration.
- Expansion devices of a wide variety of sizes and shapes may be constructed by altering the geometry of the inelastic balloon 112 or the mold 202 . Accordingly, an ePTFE expansion device having a size and shape tailored to a particular function can be manufactured in accordance with the manufacturing methods of the present invention by selecting an inelastic balloon having the desired size and shape. Exemplary expandable fluoropolymer medical treatment devices of different size and shapes are illustrated in FIGS. 7 A- 7 C.
- FIG. 7A illustrates a radially expandable treatment device 10 A having a generally pear-shaped configuration when inflated.
- the pear shaped configuration is particularly suited for removal of obstructions, such as thrombi and emboli, from a body passage.
- the expandable treatment device 10 A has an increased diameter section 226 that tapers to a reduced diameter section 228 .
- the diameter of the increased diameter section 226 is preferably equal to or slightly less than the diameter of the body passage.
- the increased diameter section 226 is the primary mechanism for removing obstructions from the body passage and, thus, preferably substantially fills the entire diameter of the body passage to facilitate complete removal of all obstructions from the body passage.
- the pear-shaped configuration provides the expandable treatment device 10 A with a limited, reduced surface area, the increased diameter section 226 , which can engage the walls of the body passage and thus minimizes potential damage to the walls of the body passage.
- FIGS. 7B and 7C illustrate alternative exemplary embodiments of the expandable device of the present invention, each providing the device with a reduced surface area for contacting the walls of a body passage.
- FIG. 7B illustrates a substantially hour-glass shaped expandable treatment device 10 B including, when inflated, a first increased diameter section 229 that tapers to a reduced diameter section 230 that expands to a second increased diameter section 231 .
- the first and second increased diameter sections 229 and 231 preferably have a diameter equal to or slightly less than the diameter of a body passage to be treated to facilitate complete removal of obstructions from the body passage.
- FIG. 7C illustrates a third exemplary embodiment in which two axially aligned expandable devices 10 C and 10 D are provided.
- the dual expandable devices 10 C and 1 OD together provide a substantially hour-glass configuration that provides the devices with two increased diameter sections 232 and 236 .
- One feature of the manufacturing processes of the present invention is that the properties of the ePTFE tube 110 forming the expandable device 10 can be manipulated, by varying the extrusion and expansion process parameters, to produce a radially expandable device 10 having different expansion characteristics.
- the longitudinal stretch ratio of the ePTFE tube 110 i.e., the ratio of final stretched length of the tube to the initial length
- the diametric stretch ratio of the ePTFE tube 110 i.e., the ratio of the final diameter, after longitudinal stretching, and the initial diameter
- the stretch rate can be varied to yield an expansion device having different radial expansion properties.
- ePTFE tube 110 having different characteristics.
- the ePTFE tube 110 can be manufactured to have a porosity that allows for the fluid utilized to radially deploy the ePTFE tube to the expanded configuration to permeate through the walls of the ePTFE tube at a desired flow rate.
- the process for producing such a microporous ePTFE tube is described in detail in Applicants' copending U.S. patent application Ser. No. ______ (Attorney Docket No. ATA-257), filed on ______, which is incorporated herein by reference.
- FIG. 8 illustrates an exemplary embodiment of the expandable device of the present invention in which the expandable device 10 E is utilized as a catheter deployed dilation balloon 300 for the treatment of a blood vessel 310 partially occluded by plaque deposits 312 adhered to the walls 314 of the blood vessel.
- the dilation balloon 300 can be manufactured in accordance with the methods of the present invention and is shown in the expanded configuration.
- the ends 302 of the dilation balloon 300 are bonded to a catheter tube 320 , which is used to provide an inflation fluid to the balloon 300 to effect expansion of the balloon 300 to a predefined and fixed maximum diameter.
Abstract
Description
- This application claims priority to Provisional Application Ser. No. 60/117,152, filed Jan. 25, 1999, and incorporated herein by reference.
- Radially expandable devices are utilized in a wide range of applications including a number of biological applications. Radially expandable devices in the form of inflatable balloons have been proposed for treatment of body passages occluded by disease and for maintenance of the proper position of catheter delivered medical devices within such body passages. Such expandable devices can be constructed of elastomeric materials such as latex. A number of general problems are associated with such elastomeric balloons. Balloons and other expansion devices constructed of elastomeric materials can lack a maximum inflation or expansion diameter in that the prolonged application of an inflation medium will cause the balloon to continuously expand until the balloon bursts. Thus, over inflation of an elastomeric balloon may result in damage to the body vessel or organ being treated or may result in the balloon bursting within the body. Elastomeric balloons frequently do not inflate symmetrically and may not inflate to the desired size and shape. Asymmetrical expansion, as well as failure of the balloon to properly inflate, can lead to incomplete treatment of the body vessel. The high coefficient of friction of most elastomeric materials, such as latex, can result in damage to one or more cellular layers of the wall of the body vessel or organ being treated. Additionally, elastomeric expansion devices generally have insufficient strength for a number of applications, such as compressing deposits formed on vascular walls and positioning catheter delivered medical devices.
- The present invention provides a radially expandable device having a body constructed a fluoropolymer material, such as expanded polytetrafluoroethylene (ePTFE). The use of fluoropolymer materials provides a radial expandable device having a biocompatible and inelastic construction that is suitable for numerous uses including the treatment of body vessels, organs, and implanted grafts. The body of the radially expandable device has a longitudinal axis and a wall having a thickness transverse to the longitudinal axis. The wall of the body is characterized by a microstructure of nodes interconnected by fibrils. The body of the radially expandable device is deployable from a reduced diameter, collapsed configuration to an increased diameter, expanded configuration upon application of an expansion force to the radially expandable device. Along at least a portion of the body, substantially all the nodes of the microstructure are oriented generally perpendicularly to the longitudinal axis of the body. This orientation of the nodes, perpendicular to the longitudinal axis of the body, yields a radially expandable device that predictably and dependably expands to the increased diameter configuration.
- According to one aspect of the present invention, the body of the radially expandable device has a monolithic construction. The term “monolithic”, as used herein, includes structures having a singular, unitary construction of generally homogenous material. The monolithic body of the radially expandable device of the present invention is characterized by a seamless construction of fluoropolymer material, such as expanded polytetrafluoroethylene (ePTFE), preferably constructed through an extrusion and expansion process. Because the cross section of the monolithic body is singular or unitary, the expandable device lacks seams or internal interfaces between adjacent layers that can result in unreliable expansion of the device. The monolithic construction of the body of the present invention contributes to the dependable and predictable expansion of the body to a predefined, fixed maximum diameter that is generally independent of the expansion force used to radially expand the device.
- In accordance with a further aspect of the present invention, a method is provided for manufacturing a radially expandable device constructed of a fluoropolymer material such as, for example, ePTFE. The method includes the step of forming a tube of fluoropolymer material having an initial diameter. A radial expansion force is applied to the tube to expand the tube from the initial diameter to a second diameter. The expansion force is then removed. The resultant tube is radially expandable from a reduced diameter to the second diameter upon application of a radial deployment force from a deployment mechanism within the tube. The deployment mechanism can be, for example, a fluid injected into the tube or a radial expansion element inserted into the tube.
- A radially expandable device constructed in accordance with the method of the present invention can be dependably and predictably expanded to the second diameter upon the application of a radially deployment force within the tube. The second diameter can be predefined and fixed to a maximum expansion diameter through the manufacturing process of the present invention, resulting in an expansion device having a maximum expansion diameter that is generally independent of the radial deployment force applied to the device.
- The fluoropolymer tube can be constructed through an extrusion and expansion process including the step of creating a billet by blending a mixture of a fluoropolymer and a lubricant and compressing the mixture. The fluoropolymer is preferably PTFE. The billet can then be extruded to form an extruded article. The lubricant is removed and the extruded article is expanded to form a monolithic tube of inelastic, expanded fluoropolymer material. The stretched tube is then heat set to lock in the microstructure of the tube and maintain the tube in the stretched state.
- The extruded article is preferably bilaterally stretched in two opposing directions along the longitudinal axis of the article. Bilaterally stretching the extruded article yields an article that is substantially uniformly stretched over a major portion of its length and has a microstructure of nodes interconnected by fibrils. The bilateral stretching step can be carried out by displacing the ends of the extruded article either simultaneously or sequentially. The longitudinal stretch ratio of the expanded tube, i.e., the ratio of the final stretched length of the tube to the initial length, and the diametric stretch ratio, i.e., the ratio of the final diameter, after longitudinal stretching, and the initial diameter, can be varied to yield an expansion device having differing radial expansion properties. For example, the magnitude of the deployment force necessary to expand the expansion device of the present invention can be pre-selected and manipulated by varying the stretch ratios of the fluoropolymer tube. Additionally, the stretch rate can be varied to selectively provide the expansion device with improved expansion characteristics.
- In accordance with another aspect of the present invention, the step of applying a radial expansion force to the fluoropolymer tube is carried out by inserting a balloon into the tube and expanding the balloon to apply the radial expansion force to the tube. Preferably, the balloon is constructed from an inelastic material such as, for example, polyethylene terephthalate (PET) or nylon. In a preferred embodiment, the balloon is constructed to be expandable to a predefined size and shape by inflation with a fluid. Radial expansion of the fluoropolymer tube with such an inelastic balloon imparts the predetermined size and shape of the balloon to the expanded fluoropolymer balloon.
- In accordance with a further aspect of the present invention, the step of radially expanding the fluoropolymer tube plastically deforms the tube beyond its elastic limit to the second diameter. Plastically deforming the fluoropolymer tube to the second diameter contributes to expansion device dependably expanding to the second diameter upon application of the radial deployment force.
- The step of radially expanding the fluoropolymer tube can also include the steps of positioning the tube within the internal cavity of a mold fixture and radially expanding the balloon within the tube while the tube remains positioned in the internal mold cavity. The internal mold cavity preferably has a size and shape analogous to the predefined size and shape of the balloon. The internal cavity of the mold facilitates concentric radial expansion of the balloon and the fluoropolymer tube.
- In accordance with another aspect of the present invention, the step of applying a radial expansion force to the fluoropolymer tube is carried out by inserting a second tube constructed from an extruded inelastic material, such as extruded PET, into the fluoropolymer tube and expanding the second tube to apply the radial expansion force to the tube. Preferably, the fluoropolymer tube and the second tube are heated to a temperature less than or equal to the glass transition temperature of the extruded material forming the second tube during the radial expansion step. The heating of the tubes can be accomplished by submerging the tubes into a hot water bath. Alternatively, the fluoropolymer tube can be expanded by the second tube within a heated mold.
- In accordance with a further aspect of the present invention, the radially expandable device of the present invention is particularly suited for treatment of body passages occluded by disease. The expandable device can be utilized in the manner of a catheter balloon suitable for deployment within a body vessel by a catheter. Exemplary treatment applications of the present application include dilation of stenoic blood vessels in a percutaneous transluminal angioplasty procedure (PTA), removal of thrombi and emboli from obstructed blood vessels, urethra dilation to treat prostatic enlargement due to benign prostate hyperplasia (BPH) or prostatic cancer, and generally restoring patency to implanted grafts or body passages such as blood vessels, the urinary tract, the intestinal tract, the kidney ducts, or other body passages.
- These and other features and advantages of the present invention will be more fully understood by reference to the following detailed description in conjunction with the attached drawings in which like reference numerals refer to like elements through the different views. The drawings illustrate principles of the invention and, although not to scale, show relative dimensions.
- FIG. 1 is a side elevational view in cross-section of a radially expandable device according to the teachings of the present invention, illustrating the device in a first, reduced diameter configuration;
- FIG. 2 is a side elevational view in cross-section of the radially expandable device of FIG. 1, illustrating the device in a second, increased diameter configuration;
- FIG. 3 is a schematic representation of the microstructure of a section of the wall of an expanded fluoropolymer tube used during the manufacturing process of the present invention to yield the radially expandable device of the present invention;
- FIG. 4A is a side elevational view in cross-section of an inelastic balloon positioned within an expanded fluoropolymer tube, illustrating the inelastic balloon in a deflated condition in accordance with a method of manufacturing a radially expandable device according to the teachings of the present invention;
- FIG. 4B is a side elevational view in cross-section of the inelastic balloon and the expanded fluoropolymer tube of FIG. 4A, illustrating the inelastic balloon in an inflated condition in accordance with a method of manufacturing a radially expandable device according to the teachings of the present invention;
- FIG. 4C is a side elevational view in cross-section of the inelastic balloon and the expanded fluoropolymer tube of FIG. 4A, illustrating the removal of the deflated inelastic balloon from the expanded fluoropolymer tube in accordance with a method of manufacturing a radially expandable device according to the teachings of the present invention;
- FIG. 5 is a side elevational view of an inelastic balloon and an expanded fluoropolymer tube positioned within the internal cavity of a mold fixture, illustrating the inelastic balloon in a inflated condition in accordance with a method of manufacturing a radially expandable device according to the teachings of the present invention;
- FIG. 6A is a flow chart illustrating the steps of manufacturing a radially expandable device according to the teachings of the present invention;
- FIG. 6B is a flow chart illustrating the steps of an alternative method of manufacturing a radially expandable device according to the teachings of the present invention;
- FIG. 7A is a side elevational view in cross section of a generally pear-shaped radially expandable device in accordance with the teaching of the present invention;
- FIG. 7B is a side elevational view in cross section of a generally hour glass shaped radially expandable device in accordance with the teaching of the present invention;
- FIG. 7C is a side elevational view in cross section of two coaxially aligned, adjacent radially expandable devices in accordance with the teaching of the present invention; and
- FIG. 8 is a side elevational view in cross section of a catheter deployed dilation balloon according to the teaching of the present invention, illustrating the dilation balloon expanded within a body vessel.
- A radially
expandable device 10 having abody 12 constructed of a generally inelastic, expanded fluoropolymer material is illustrated in FIGS. 1 and 2. Expandable devices provided by the present invention are suitable for a wide range of applications including, for example, a range of medical treatment applications. Exemplary biological applications include use as a catheter balloon for treatment of implanted grafts and body passages such as blood vessels, the urinary tract, the intestinal tract, kidney ducts, etc. Specific examples include as a device for the removal of obstructions such as emboli and thrombi from blood vessels, as a dilation device to restore patency to an occluded body passage as an occlusion device to selectively obstruct a body passage, and as a centering mechanism for transluminal instruments and catheters. The expandable device of the present invention can also be used as a sheath for covering conventional catheter balloons to control the expansion of the conventional balloon. - The
body 12 of the radiallyexpandable device 10 is deployable upon application of an expansion force from a first, reduced diameter configuration, illustrated in FIG. 1, to a second, increased diameter configuration, illustrated in FIG. 2. Thebody 12 of theexpansion device 10 of the present invention preferably features a monolithic construction, i.e., thebody 12 is a singular, unitary article of generally homogeneous material. Thebody 12 is manufactured in accordance with the methods of manufacturing of the present invention, an extrusion and expansion process described in detail below, to yield abody 12 characterized by a seamless construction of inelastic, expanded fluoropolymer having a predefined size and shape in the second, increased diameter configuration. Thebody 12 can be dependably and predictably expanded to the predefined, fixed maximum diameter and to the predefined shape independent of the expansion force used to expand the device. - Referring specifically to FIG. 2, the
body 12 of theradial expansion device 10 of the present invention is preferably generally tubular in shape when expanded, although other cross sections, such as rectangular, oval, elliptical, or polygonal, can be utilized. The cross section of thebody 12 is preferably continuous and uniform along the length of the body. However, in alternative embodiments, the cross section can vary in size and/or shape along the length of the body. FIG. 1 illustrates thebody 12 relaxed in the first, reduced diameter configuration. Thebody 12 has acentral lumen 13 extending along alongitudinal axis 14 between afirst end 16 andsecond end 18. - A deployment mechanism in the form of an elongated
hollow tube 20 is shown positioned within thecentral lumen 13 to provide a radial deployment or expansion force to thebody 12. The radial deployment force effects radial expansion of thebody 12 from the first configuration to the second increased diameter configuration illustrated in FIG. 2. Thefirst end 16 and thesecond end 18 are connected in sealing relationship to the outer surface of thehollow tube 20. The first and second ends 16 and 18 can be thermally bonded, bonded by means of an adhesive, or attached by other means suitable for inhibiting fluid leakage from the first and second ends 16 and 18 between the walls of thebody 12 and thetube 20. - The
hollow tube 20 includes an internal, longitudinal extendinglumen 22 and a number of side-holes 24 that provide for fluid communication between the exterior of thetube 20 and thelumen 22. Thetube 20 can be coupled to a fluid source (not shown) to selectively provide fluid, such as water, saline, or air, to thelumen 13 of thebody 12 through thelumen 22 and side-holes 24. The pressure from the fluid provides a radial expansion force on thebody 12 to radial expand thebody 12 to the second, increased diameter configuration. Because thebody 12 is constructed from an inelastic material, uncoupling thetube 20 from the fluid source or otherwise substantially reducing the fluid pressure within thelumen 13 of thebody 12, does not generally result in thebody 12 returning to the first, reduced diameter configuration. However, thebody 12 will collapse under its own weight to a reduced diameter. Application of negative pressure, from, for example, a vacuum source, can be used to completely deflate thebody 12 to the initial reduced diameter configuration. - One skilled in the art will appreciate that the
expansion device 10 of the present invention is not limited to use with deployment mechanisms employing a fluid deployment force, such ashollow tube 20. Other known deployment mechanisms can be used to radially deploy theexpansion device 10 including, for example, mechanical operated expansion elements, such as mechanically activated members or mechanical elements constructed from temperature activated materials such as nitinol. - Various fluoropolymer materials are suitable for use in the present invention. Suitable fluoropolymer materials include, for example, polytetrafluoroethylene (PTFE) or copolymers of tetrafluoroethylene with other monomers may be used. Such monomers include ethylene, chlorotrifluoroethylene, perfluoroalkoxytetrafluoroethylene, or fluorinated propylenes such as hexafluoropropylene. PTFE is the preferred material of choice. Accordingly, while the
radial expansion device 10 can be manufactured from various fluoropolymer materials, and the manufacturing methods of the present invention can utilize various fluoropolymer materials, the description set forth herein refers specifically to PTFE. - A method of manufacturing a radially expandable device in accordance with the present invention will be described in connection with FIGS.4A-4C and the flow chart shown in FIG. 6A. The radially
expandable device 10 of the present invention is produced from atube 110 constructed of expanded fluoropolymer material, which is preferably produced through an extrusion and a longitudinal expansion process. The preferred fluoropolymer material is expanded PTFE (ePTFE), which is a hydrophobic, biocompatible, inelastic material having a low coefficient of friction, although, as discussed above, other inelastic, biocompatible fluoropolymer materials may be used. - To produce the ePTFE tube, a billet comprising a PTFE resin mixed with an organic lubricant is utilized. Various organic lubricants are suitable such as naphtha, ISOPAR-G and ISOPAR-H available from Exxon Corporation. The blended resin is compressed at low pressure to yield a tubular billet of PTFE resin and lubricant, step210 of FIG. 6A. The tubular billet is then extruded through an extruder, for example a ram extruder, to reduce the cross section of the billet and to yield a tubular extrudate,
step 212. The organic lubricant can be removed from the extrudate by drying the extrudate in a heated oven,step 214. - Once the tubular extrudate is produced, the extrudate is expanded by longitudinal stretching,
step 216. Preferably, the extrudate is bilaterally stretched. Bilateral stretching is accomplished by displacing both ends of the extrudate, sequentially or simultaneously, away from the center of the extrudate. Bilateral stretching provides a material that is homogeneously stretched over the majority of its length. After the extrudate has been stretched, it is heat set to lock in the microstructure of the material, step 218 of FIG. 6A, and to complete the process of the forming thetube 110 of ePTFE. - FIG. 3 is a schematic representation of the microstructure of the walls of the
ePTFE tube 110 as formed by the extrusion and expansion process described above. For purposes of description, the microstructure of thetube 110 has been exaggerated. Accordingly, while the dimensions of the microstructure are enlarged, the general character of the illustrated microstructure is representative of the microstructure prevailing within thetube 110. - The microstructure of the
ePTFE tube 110 is characterized bynodes 130 interconnected byfibrils 132. Thenodes 130 are generally oriented perpendicular to thelongitudinal axis 114 of thetube 110. This microstructure ofnodes 130 interconnected byfibrils 132 provides a microporous structure having microfibrillar spaces which define through-pores orchannels 134 extending entirely from theinner wall 136 and theouter wall 138 of thetube 110. The through-pores 134 are perpendicularly oriented (relative to the longitudinal axis 114), internodal spaces that traverse from theinner wall 136 to theouter wall 138. The size and geometry of the through-pores 134 can be altered through the extrusion and stretching process, as described in detail in Applicants' copending U.S. patent application Ser. No. ______ (Attorney Docket No. ATA-257), filed on the same date as the present application, which is incorporated herein by reference, to yield a microstructure that is impermeable, semi-impermeable, or permeable. - In a preferred embodiment, the
ePTFE tube 110, and the resultantexpandable device 10, has a fine nodal structure that is uniform throughout the cross section and length of the ePTFE tube. The preferred uniform fine nodal structure provides theexpandable device 10 with improved expansion characteristics as the expandable device dependably and predictably expands to the second diameter. The preferred fine nodal structure is characterized by nodes having a size and mass less than the nodes found in conventional ePTFE grafts, preferably in the range of 25 μm-30 μm. Additionally, the spacing between the nodes, referred to as the internodal distance, and the spacing between the fibers, referred to as the interfibril distance, is also preferably less than found in conventional ePTFE grafts, preferably in the range of 1 μm-5 μm. Moreover, the internodal distance and the interfibril distance in the preferred embodiment is preferably uniform throughout the length and the cross section of the ePTFE tube. The preferred uniform nodal structure can be created by forming the billet with a uniform lubricant level throughout its cross section and length. Stretching the tubular extrudate at higher stretch rates, for example at rates greater than 1 in/s, yields the preferred fine nodal structure. Preferably, the extrudate is stretched at a rate of approximately 10 in/s or greater. - Continuing to describe the manufacturing method of the present invention and referring again to FIGS. 4A and 6A, the
ePTFE tube 110, having an initial diameter d, is pulled over aballoon 112 to position theballoon 112 within thelumen 114 of thetube 110, step 220 of FIG. 6A. Theballoon 112 is preferably constructed of an inelastic material such as, for example, PET or nylon, such that theballoon 112, when inflated, attains a predetermined size and shape. Theballoon 112 can be bonded or otherwise coupled to a rigid catheter or hypo-tube 116 to facilitate placement and removal of the ePTFE tube as described below. Thecatheter 116 has acentral inflation lumen 118 and a plurality of side-holes 120 to provide for the delivery of an inflation fluid to inflate theballoon 112. - Referring specifically to FIG. 4B, the
balloon 112 can be inflated by introduction of a pressurized fluid to thelumen 114 of theePTFE tube 110. The overlyingePTFE tube 110 expands with the inelastic balloon 122 until both theballoon 112 and theePTFE tube 110 obtain the predetermined size and shape of theinflated balloon 112, step 222 of FIG. 6A. Theinflated balloon 112 thus imparts its predetermined size and shape to theePTFE tube 110. This radially expansion process is referred to as blow-molding. ThePTFE tube 110 shown in FIG. 4B is radially expanded from the initial diameter d (FIG. 4A) to an increased diameter D. This radial expansion process may take place in an air, water, or steam-heated chamber that is heated to a temperature between 35° C. and 60° C., preferably 50° C. The elevated temperature can contribute to uniform expansion, both circumferentially and longitudinally, of the ePTFE balloon, as well as uniform wall thickness. - It is preferable for the
ePTFE tube 110 to be plastically deformed by the radial expansion of theinelastic balloon 112, step 222 of FIG. 6A. The terms “plastic deformation” and “plastically deform,” as used herein, is intended to include the radial expansion of theePTFE tube 110 beyond the elastic limit of the ePTFE material such that the ePTFE material is permanently deformed. Once plastically deformed, the ePTFE material forming thetube 110 becomes substantially inelastic, i.e., the ePTFE tube generally will not, on its own, return to its pre-expansion size and shape. - The
ePTFE tube 110 can be removed from theballoon 112 by sliding theePTFE tube 110 relative to balloon 112 andcatheter 116, i.e. in the direction of arrows A in FIG. 4C, step 224 of FIG. 6A. Thetube 110 can be heat set at a temperature above the sinter point of the material forming the tube, 360° C. for ePTFE, to lock in the structure of thetube 110, step 225 of FIG. 6A. - The resultant radially expanded
ePTFE tube 110, produced in accordance with the above described method, provides a radially expandable device, such asexpandable device 10 illustrated in FIGS. 1 and 2 and described above, that is radially expandable from a relaxed, collapsed diameter to the second, increased diameter D upon application of a radial deployment force from a deployment mechanism, e.g.,hollow tube 20, within thetube 110. TheePTFE tube 110 further provides anexpansion device 10 having monolithic construction, that is, a singular, unitary construction of generally homogenous material, ePTFE, that lacks seams or other internal interfaces. TheePTFE tube 110 can be dependably and predictably expanded to the second diameter D upon the application of the radially deployment force within the tube. In particular, the plastically deformed, monolithic microstructure of theePTFE tube 110, once radially expanded by theinelastic balloon 120, will readily return to the increased diameter D upon application of a radial deployment force and generally will not expand beyond the increased diameter D. The increased diameter D is effectively the maximum expansion diameter for the ePTFE tube, as the increased diameter D is generally independent of the radial deployment force applied to the tube. - Referring to FIG. 5, an alternative method of manufacturing a radially expandable device employing a
mold 202 is illustrated. Themold 202 includes twointerconnected sections 204 and 206 forming aninternal mold cavity 208 for receiving theePTFE tube 110 with theballoon 112 positioned therein. Themold 202 is preferably constructed of a rigid, unyielding material such as a metal or metal alloy. Suitable metals or metal alloys include brass and steel alloys. Theinternal mold cavity 208 preferably has a size and shape analogous to that of theinflated balloon 112 to ensure that theinflated balloon 112, and theoverlying ePTFE tube 110 concentrically expand. - Referring to the flow chart illustrated in FIG. 6B, a further alternative method of manufacturing a radially expandable device according to the teachings of the present invention will be described. A tube constructed of ePTFE is formed in accordance with the methods described above,
step 410. A tube formed of an extruded inelastic material such as PET is used in place ofballoon 112 to radially expand the ePTFE tube. The extruded tube is positioned within theePTFE tube 110,step 412. The extruded tube is then sealed at one end and attached to an inflation system at the other end,step 414. The extruded tube can then be inflated by an inflation medium to radially expand the ePTFE tube,step 416. The extruded tube and ePTFE tube are preferably heated to the glass transition temperature of the extruded tube, approximately 80° C.-100° C. for PET, as the extruded tube is inflated within the ePTFE tube. It is preferable to limit the temperature of the extruded tube to a temperature less than or equal to the glass transition temperature of the material forming the extruded tube to facilitate removal of the extruded tube from the ePTFE tube. Heating the extruded tube to a temperature above the glass transition temperature will cause the extruded tube to heat set in an expanded configuration, which makes removing the extruded tube from the ePTFE tube difficult. A suitable inflation system employing a hot water chamber for heating the tubes is described in Applicants copending U.S. patent application Ser. No. ______ (Attorney Docket No. ATA-257), filed on the same date as the present application, which is incorporated herein by reference. - After the extruded tube and ePTFE tube are expanded to desired size and shape, the extruded tube is deflated and removed from the ePTFE tube,
step 418. The ePTFE tube is then heat set to lock in the structure of the ePTFE tube,step 420. - A mold, such as
mold 202, can be employed during radial expansion of the ePTFE tube using the PET tube. The mold is preferably heated within the hot water chamber of the inflation system or by other means such as a hot oil bath or through a steam, hot air, electric, radio frequency or infra red heat source. The mold can be constructed of a material having good heat transfer characteristics, such as metal or metal alloy, for example brass. The mold includes a mold cavity having a size and shape analogous to the desired size and shape of the radiallyexpandable device 10 in the second diameter configuration. - Expansion devices of a wide variety of sizes and shapes may be constructed by altering the geometry of the
inelastic balloon 112 or themold 202. Accordingly, an ePTFE expansion device having a size and shape tailored to a particular function can be manufactured in accordance with the manufacturing methods of the present invention by selecting an inelastic balloon having the desired size and shape. Exemplary expandable fluoropolymer medical treatment devices of different size and shapes are illustrated in FIGS. 7A-7C. - FIG. 7A illustrates a radially
expandable treatment device 10A having a generally pear-shaped configuration when inflated. The pear shaped configuration is particularly suited for removal of obstructions, such as thrombi and emboli, from a body passage. Theexpandable treatment device 10A has an increaseddiameter section 226 that tapers to a reduceddiameter section 228. The diameter of the increaseddiameter section 226 is preferably equal to or slightly less than the diameter of the body passage. The increaseddiameter section 226 is the primary mechanism for removing obstructions from the body passage and, thus, preferably substantially fills the entire diameter of the body passage to facilitate complete removal of all obstructions from the body passage. The pear-shaped configuration provides theexpandable treatment device 10A with a limited, reduced surface area, the increaseddiameter section 226, which can engage the walls of the body passage and thus minimizes potential damage to the walls of the body passage. - FIGS. 7B and 7C illustrate alternative exemplary embodiments of the expandable device of the present invention, each providing the device with a reduced surface area for contacting the walls of a body passage. In particular, FIG. 7B illustrates a substantially hour-glass shaped
expandable treatment device 10B including, when inflated, a first increaseddiameter section 229 that tapers to a reduceddiameter section 230 that expands to a second increaseddiameter section 231. As in the case of the exemplary embodiment described above and illustrated in FIG. 7A, the first and second increaseddiameter sections - FIG. 7C illustrates a third exemplary embodiment in which two axially aligned expandable devices10C and 10D are provided. As is the case of the second exemplary embodiment described above, the dual expandable devices 10C and 1 OD together provide a substantially hour-glass configuration that provides the devices with two increased
diameter sections 232 and 236. - One feature of the manufacturing processes of the present invention is that the properties of the
ePTFE tube 110 forming theexpandable device 10 can be manipulated, by varying the extrusion and expansion process parameters, to produce a radiallyexpandable device 10 having different expansion characteristics. For example, the longitudinal stretch ratio of theePTFE tube 110, i.e., the ratio of final stretched length of the tube to the initial length, and the diametric stretch ratio of theePTFE tube 110, i.e., the ratio of the final diameter, after longitudinal stretching, and the initial diameter, and the stretch rate can be varied to yield an expansion device having different radial expansion properties. Applicants determined that larger longitudinal stretch ratios, in the order of 2:1 to 3:1, can result in a ePTFE tube having a microstructure characterized by increased internodal distances and interstitial space. Suitable longitudinal stretch ratios can be from 1.1:1 to 10:1. As discussed above, Applicants determined that increased stretch rates yield an ePTFE tube having a fine nodal structure conducive to radial expansion. Expansion devices constructed from ePTFE tubes having such larger longitudinal and/or diametric stretch ratios and which are stretched at increased rates generally require less radial deployment force to expand from the collapsed, reduced diameter configuration to the expanded, increased diameter configuration. Thus, the magnitude of the radial deployment force necessary to expand theePTFE tube 110 can be pre-selected and manipulated by varying the stretch ratios and stretch rate of theePTFE tube 110 during the manufacturing process. - In addition to the longitudinal and diametric stretch ratios and the stretch rate, further process parameters can be varied to produce an
ePTFE tube 110 having different characteristics. For example, theePTFE tube 110 can be manufactured to have a porosity that allows for the fluid utilized to radially deploy the ePTFE tube to the expanded configuration to permeate through the walls of the ePTFE tube at a desired flow rate. The process for producing such a microporous ePTFE tube is described in detail in Applicants' copending U.S. patent application Ser. No. ______ (Attorney Docket No. ATA-257), filed on ______, which is incorporated herein by reference. - FIG. 8 illustrates an exemplary embodiment of the expandable device of the present invention in which the
expandable device 10E is utilized as a catheter deployeddilation balloon 300 for the treatment of a blood vessel 310 partially occluded byplaque deposits 312 adhered to thewalls 314 of the blood vessel. Thedilation balloon 300 can be manufactured in accordance with the methods of the present invention and is shown in the expanded configuration. The ends 302 of thedilation balloon 300 are bonded to acatheter tube 320, which is used to provide an inflation fluid to theballoon 300 to effect expansion of theballoon 300 to a predefined and fixed maximum diameter. - It will thus be seen that the invention efficiently attains the objects made apparent from the preceding description. Since certain changes may be made in the above constructions without departing from the scope of the invention, it is intended that all matter contained in the above description or shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense.
- It is also to be understood that the following claims are to cover all generic and specific features of the invention described herein, and all statements of the scope of the invention which, as a matter of language, might be said to fall therebetween.
Claims (34)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/410,329 US6395208B1 (en) | 1999-01-25 | 1999-10-01 | Method of making an expandable fluoropolymer device |
DE60027136T DE60027136T2 (en) | 1999-01-25 | 2000-01-24 | EXPERIENCE OF FLUOROPOLYMERS FOR THE ADMINISTRATION OF THERAPEUTIC ACTIVE SUBSTANCES |
PCT/US2000/002191 WO2000043051A1 (en) | 1999-01-25 | 2000-01-24 | Expandable fluoropolymer device for delivery of therapeutic agents |
AT00913281T ATE322296T1 (en) | 1999-01-25 | 2000-01-24 | EXPANDABLE DEVICE MADE OF FLUROPOLYMERS FOR ADMINISTRATION OF THERAPEUTIC ACTIVE INGREDIENTS |
AU34752/00A AU3475200A (en) | 1999-01-25 | 2000-01-24 | Expandable fluoropolymer device for delivery of therapeutic agents |
EP00913281A EP1148899B1 (en) | 1999-01-25 | 2000-01-24 | Expandable fluoropolymer device for delivery of therapeutic agents |
US10/131,396 US7637886B2 (en) | 1999-01-25 | 2002-04-22 | Expandable fluoropolymer device and method of making |
US11/804,478 US7947015B2 (en) | 1999-01-25 | 2007-05-18 | Application of a therapeutic substance to a tissue location using an expandable medical device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11715299P | 1999-01-25 | 1999-01-25 | |
US09/410,329 US6395208B1 (en) | 1999-01-25 | 1999-10-01 | Method of making an expandable fluoropolymer device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/131,396 Continuation-In-Part US7637886B2 (en) | 1999-01-25 | 2002-04-22 | Expandable fluoropolymer device and method of making |
Publications (2)
Publication Number | Publication Date |
---|---|
US20020050661A1 true US20020050661A1 (en) | 2002-05-02 |
US6395208B1 US6395208B1 (en) | 2002-05-28 |
Family
ID=26814975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/410,329 Expired - Lifetime US6395208B1 (en) | 1999-01-25 | 1999-10-01 | Method of making an expandable fluoropolymer device |
Country Status (1)
Country | Link |
---|---|
US (1) | US6395208B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040236308A1 (en) * | 2003-05-22 | 2004-11-25 | Atrium Medical Corp. | Kinetic isolation pressurization |
JP2019069003A (en) * | 2017-10-10 | 2019-05-09 | 株式会社ピーアールシー | Method and device for attaching balloon to catheter |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010001113A1 (en) * | 1998-04-21 | 2001-05-10 | Florencia Lim | Balloon catheter |
US6290728B1 (en) * | 1998-09-10 | 2001-09-18 | Percardia, Inc. | Designs for left ventricular conduit |
US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
US6261304B1 (en) | 1998-09-10 | 2001-07-17 | Percardia, Inc. | Delivery methods for left ventricular conduit |
US6955661B1 (en) * | 1999-01-25 | 2005-10-18 | Atrium Medical Corporation | Expandable fluoropolymer device for delivery of therapeutic agents and method of making |
US6302892B1 (en) | 1999-08-04 | 2001-10-16 | Percardia, Inc. | Blood flow conduit delivery system and method of use |
US6602224B1 (en) * | 1999-12-22 | 2003-08-05 | Advanced Cardiovascular Systems, Inc. | Medical device formed of ultrahigh molecular weight polyolefin |
US6428506B1 (en) * | 1999-12-22 | 2002-08-06 | Advanced Cardiovascular Systems, Inc. | Medical device formed of ultrahigh molecular weight polyethylene |
JP3782297B2 (en) * | 2000-03-28 | 2006-06-07 | 株式会社東芝 | Solid-state imaging device and manufacturing method thereof |
US6854467B2 (en) * | 2000-05-04 | 2005-02-15 | Percardia, Inc. | Methods and devices for delivering a ventricular stent |
US20020032478A1 (en) * | 2000-08-07 | 2002-03-14 | Percardia, Inc. | Myocardial stents and related methods of providing direct blood flow from a heart chamber to a coronary vessel |
US6743388B2 (en) * | 2001-12-31 | 2004-06-01 | Advanced Cardiovascular Systems, Inc. | Process of making polymer articles |
US6929768B2 (en) * | 2002-05-13 | 2005-08-16 | Advanced Cardiovascular Systems, Inc. | Method of making a catheter balloon by laser fusing wrapped material |
US6863852B1 (en) * | 2002-05-30 | 2005-03-08 | Zeus Industrial Products, Inc. | Fluoropolymer extrusions based on novel combinations of process parameters and clay minerals |
US7326219B2 (en) * | 2002-09-09 | 2008-02-05 | Wilk Patent Development | Device for placing transmyocardial implant |
US6928669B2 (en) * | 2003-01-10 | 2005-08-16 | Tyler Pipe Company | Closet carrier system and method of assembly |
US7632291B2 (en) | 2003-06-13 | 2009-12-15 | Trivascular2, Inc. | Inflatable implant |
US20050127561A1 (en) * | 2003-12-16 | 2005-06-16 | Scimed Life Systems, Inc. | Method of making expandable-collapsible bodies by temperature gradient expansion molding |
US7468051B2 (en) * | 2004-03-02 | 2008-12-23 | Boston Scientific Scimed, Inc. | Occlusion balloon catheter with external inflation lumen |
US7198632B2 (en) * | 2004-03-02 | 2007-04-03 | Boston Scientific Scimed, Inc. | Occlusion balloon catheter with longitudinally expandable balloon |
US7524445B2 (en) * | 2004-12-31 | 2009-04-28 | Boston Scientific Scimed, Inc. | Method for making ePTFE and structure containing such ePTFE, such as a vascular graft |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US8663308B2 (en) | 2005-09-19 | 2014-03-04 | Cook Medical Technologies Llc | Graft with bioabsorbable support frame |
US8162878B2 (en) | 2005-12-05 | 2012-04-24 | Medrad, Inc. | Exhaust-pressure-operated balloon catheter system |
JP2009519770A (en) | 2005-12-16 | 2009-05-21 | インターフェイス・アソシエイツ・インコーポレーテッド | Medical multilayer balloon and method for producing the same |
AU2008224435B2 (en) | 2007-03-15 | 2014-01-09 | Ortho-Space Ltd. | Prosthetic devices and methods for using same |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
CN101917929A (en) | 2007-10-04 | 2010-12-15 | 特里瓦斯库拉尔公司 | Modular vascular graft for low profile percutaneous delivery |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
WO2009079539A1 (en) | 2007-12-17 | 2009-06-25 | Medrad, Inc. | Rheolytic thrombectomy catheter with self-inflation distal balloon |
US8439878B2 (en) | 2007-12-26 | 2013-05-14 | Medrad, Inc. | Rheolytic thrombectomy catheter with self-inflating proximal balloon with drug infusion capabilities |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
WO2011104269A1 (en) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US8226603B2 (en) * | 2008-09-25 | 2012-07-24 | Abbott Cardiovascular Systems Inc. | Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery |
US8076529B2 (en) | 2008-09-26 | 2011-12-13 | Abbott Cardiovascular Systems, Inc. | Expandable member formed of a fibrous matrix for intraluminal drug delivery |
US8049061B2 (en) * | 2008-09-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery |
WO2011119536A1 (en) | 2010-03-22 | 2011-09-29 | Abbott Cardiovascular Systems Inc. | Stent delivery system having a fibrous matrix covering with improved stent retention |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
US9415193B2 (en) | 2011-03-04 | 2016-08-16 | W. L. Gore & Associates, Inc. | Eluting medical devices |
US9808605B2 (en) | 2011-10-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Controlled porosity devices for tissue treatments, methods of use, and methods of manufacture |
WO2013057566A2 (en) | 2011-10-18 | 2013-04-25 | Ortho-Space Ltd. | Prosthetic devices and methods for using same |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
US9901715B2 (en) | 2012-09-05 | 2018-02-27 | W. L. Gore Associates, Inc. | Retractable sheath devices, systems, and methods |
CN105491978A (en) | 2013-08-30 | 2016-04-13 | 耶拿阀门科技股份有限公司 | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
WO2015067326A1 (en) | 2013-11-08 | 2015-05-14 | Saint-Gobain Performance Plastics Corporation | Articles containing ptfe having improved dimensional stability particularly over long lengths, methods for making such articles, and cable/wire assemblies containing such articles |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
WO2017046647A1 (en) | 2015-09-18 | 2017-03-23 | Ortho-Space Ltd. | Intramedullary fixated subacromial spacers |
EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
EP3573806A4 (en) | 2017-01-30 | 2019-12-11 | Ortho-Space Ltd. | Processing machine and methods for processing dip-molded articles |
Family Cites Families (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3635223A (en) | 1969-12-02 | 1972-01-18 | Us Catheter & Instr Corp | Embolectomy catheter |
US3981299A (en) | 1971-03-15 | 1976-09-21 | Harry Elmer Murray | Urethral catheter |
US3901232A (en) | 1973-10-26 | 1975-08-26 | Alza Corp | Integrated device for administering beneficial drug at programmed rate |
US3888249A (en) | 1973-11-02 | 1975-06-10 | David L Spencer | Arterial infusion catheter |
US4030503A (en) | 1975-11-05 | 1977-06-21 | Clark Iii William T | Embolectomy catheter |
JPS5413694A (en) | 1977-07-01 | 1979-02-01 | Sumitomo Electric Industries | Composite blood vessel prosthesis and method of producing same |
US4327721A (en) | 1978-07-07 | 1982-05-04 | George Hanover | Endotracheal tube with topical agent delivery system and method of using the same |
US4713070A (en) | 1978-11-30 | 1987-12-15 | Sumitom Electric Industries, Ltd. | Porous structure of polytetrafluoroethylene and process for production thereof |
DE3173564D1 (en) | 1980-09-02 | 1986-03-06 | Medtronic Inc | Subcutaneously implantable lead with drug dispenser means |
US4338942A (en) | 1980-10-20 | 1982-07-13 | Fogarty Thomas J | Dilatation catherter apparatus |
US4437856A (en) | 1981-02-09 | 1984-03-20 | Alberto Valli | Peritoneal catheter device for dialysis |
US4406656A (en) | 1981-06-01 | 1983-09-27 | Brack Gillium Hattler | Venous catheter having collapsible multi-lumens |
DE3235974A1 (en) | 1981-11-24 | 1983-06-01 | Volkmar Dipl.-Ing. Merkel (FH), 8520 Erlangen | DEVICE FOR REMOVAL OR FOR THE EXPANSION OF CONSTRAINTS IN BODY LIQUID LEADING VESSELS |
US4417576A (en) | 1982-02-25 | 1983-11-29 | Baran Ostap E | Double-wall surgical cuff |
US4423725A (en) | 1982-03-31 | 1984-01-03 | Baran Ostap E | Multiple surgical cuff |
US4636195A (en) | 1982-04-02 | 1987-01-13 | Harvey Wolinsky | Method and apparatus for removing arterial constriction |
US4693243A (en) | 1983-01-14 | 1987-09-15 | Buras Sharon Y | Conduit system for directly administering topical anaesthesia to blocked laryngeal-tracheal areas |
US4490421A (en) * | 1983-07-05 | 1984-12-25 | E. I. Du Pont De Nemours And Company | Balloon and manufacture thereof |
USRE32983E (en) * | 1983-07-05 | 1989-07-11 | E. I. Du Pont De Nemours And Company | Balloon and manufacture thereof |
US4714460A (en) | 1983-07-29 | 1987-12-22 | Reynaldo Calderon | Methods and systems for retrograde perfusion in the body for curing it of the disease or immume deficiency |
US4799479A (en) | 1984-10-24 | 1989-01-24 | The Beth Israel Hospital Association | Method and apparatus for angioplasty |
US4637396A (en) | 1984-10-26 | 1987-01-20 | Cook, Incorporated | Balloon catheter |
US4824436A (en) | 1985-04-09 | 1989-04-25 | Harvey Wolinsky | Method for the prevention of restenosis |
US4692200A (en) | 1985-07-30 | 1987-09-08 | Advanced Cardiovascular Systems, Inc. | Self-venting balloon dilatation catheter and method |
US4650466A (en) | 1985-11-01 | 1987-03-17 | Angiobrade Partners | Angioplasty device |
US4714461A (en) | 1985-11-07 | 1987-12-22 | Becton, Dickinson And Company | Catheter assembly with air purging feature |
JPS62236560A (en) | 1986-04-09 | 1987-10-16 | テルモ株式会社 | Catheter for repairing blood vessel |
ATE81788T1 (en) | 1986-05-08 | 1992-11-15 | Meir Lichtenstein | IMPROVEMENTS IN TISSUE-FRIENDLY, NON-THROMACULAR SURFACES. |
US4721507A (en) | 1986-06-05 | 1988-01-26 | Thomas J. Fogarty | Shear force gauge and method and apparatus for limiting embolectomy shear force |
US4744366A (en) | 1986-09-10 | 1988-05-17 | Jang G David | Concentric independently inflatable/deflatable multiple diameter balloon angioplasty catheter systems and method of use |
US4762130A (en) | 1987-01-15 | 1988-08-09 | Thomas J. Fogarty | Catheter with corkscrew-like balloon |
US4816339A (en) | 1987-04-28 | 1989-03-28 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
US5034082A (en) * | 1987-07-02 | 1991-07-23 | Prince Manufacturing, Inc. | Method of constructing a tennis racket |
US4935190A (en) * | 1987-07-10 | 1990-06-19 | William G. Whitney | Method of making balloon retention catheter |
US4820349A (en) | 1987-08-21 | 1989-04-11 | C. R. Bard, Inc. | Dilatation catheter with collapsible outer diameter |
US4850969A (en) | 1987-10-01 | 1989-07-25 | Retroperfusion Systems, Inc. | Retroperfusion catheter and tip construction for use therewith |
US5041090A (en) | 1988-01-12 | 1991-08-20 | Scheglov Viktor I | Occluding device |
DE8904026U1 (en) | 1988-04-20 | 1989-05-24 | Schneider (Europe) Ag, Zuerich, Ch | |
DE3821544C2 (en) | 1988-06-25 | 1994-04-28 | H Prof Dr Med Just | Dilatation catheter |
US4877031A (en) | 1988-07-22 | 1989-10-31 | Advanced Cardiovascular Systems, Inc. | Steerable perfusion dilatation catheter |
US4968307A (en) | 1989-01-09 | 1990-11-06 | Advanced Cardiovascular Systems, Inc. | Catheter for uniform distribution of therapeutic fluids |
US5021044A (en) | 1989-01-30 | 1991-06-04 | Advanced Cardiovascular Systems, Inc. | Catheter for even distribution of therapeutic fluids |
US5087244A (en) | 1989-01-31 | 1992-02-11 | C. R. Bard, Inc. | Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen |
DE69023362T2 (en) | 1989-01-31 | 1996-04-04 | Bard Inc C R | Catheter and method for locally applied medication of the wall of a blood vessel or other body lumen. |
US4957669A (en) * | 1989-04-06 | 1990-09-18 | Shiley, Inc. | Method for producing tubing useful as a tapered vascular graft prosthesis |
US5015232A (en) | 1989-04-20 | 1991-05-14 | Cook Incorporated | Decompression enteroclysis balloon catheter |
US4994033A (en) | 1989-05-25 | 1991-02-19 | Schneider (Usa) Inc. | Intravascular drug delivery dilatation catheter |
HU212760B (en) | 1989-06-20 | 1997-02-28 | Denes | Method and device for the apportion of chemical materials into the vein wall |
US4968306A (en) | 1989-07-07 | 1990-11-06 | Advanced Cardiovascular Systems, Inc. | Intravascular catheter having an adjustable length infusion section to delivery therapeutic fluid |
US5156610A (en) | 1989-08-18 | 1992-10-20 | Evi Corporation | Catheter atherotome |
US5282484A (en) | 1989-08-18 | 1994-02-01 | Endovascular Instruments, Inc. | Method for performing a partial atherectomy |
US5211651A (en) | 1989-08-18 | 1993-05-18 | Evi Corporation | Catheter atherotome |
US5071424A (en) | 1989-08-18 | 1991-12-10 | Evi Corporation | Catheter atherotome |
US5087394A (en) * | 1989-11-09 | 1992-02-11 | Scimed Life Systems, Inc. | Method for forming an inflatable balloon for use in a catheter |
US5135516A (en) | 1989-12-15 | 1992-08-04 | Boston Scientific Corporation | Lubricious antithrombogenic catheters, guidewires and coatings |
US5049132A (en) | 1990-01-08 | 1991-09-17 | Cordis Corporation | Balloon catheter for delivering therapeutic agents |
US5176638A (en) | 1990-01-12 | 1993-01-05 | Don Michael T Anthony | Regional perfusion catheter with improved drug delivery control |
US5199951A (en) | 1990-05-17 | 1993-04-06 | Wayne State University | Method of drug application in a transporting medium to an arterial wall injured during angioplasty |
EP0533816B1 (en) | 1990-06-15 | 1995-06-14 | Cortrak Medical, Inc. | Drug delivery apparatus |
US5087247A (en) | 1990-08-28 | 1992-02-11 | Cardiovascular Designs, Inc. | Balloon perfusion catheter |
US5192290A (en) | 1990-08-29 | 1993-03-09 | Applied Medical Resources, Inc. | Embolectomy catheter |
US5112347A (en) | 1991-05-14 | 1992-05-12 | Taheri Syde A | Embolectomy catheter, and method of operating same |
US5458568A (en) | 1991-05-24 | 1995-10-17 | Cortrak Medical, Inc. | Porous balloon for selective dilatation and drug delivery |
US5213576A (en) | 1991-06-11 | 1993-05-25 | Cordis Corporation | Therapeutic porous balloon catheter |
US5318531A (en) | 1991-06-11 | 1994-06-07 | Cordis Corporation | Infusion balloon catheter |
JPH05192408A (en) | 1991-09-06 | 1993-08-03 | C R Bard Inc | Production of expansion balloon |
DE69325649T2 (en) | 1992-03-13 | 1999-11-18 | Atrium Medical Corp | OBJECTS OF EXPANDED FLUOROPOLYMER (e.g. POLYTETRAFLUORETHYLENE) WITH CONTROLLED POROSITY AND ITS PRODUCTION |
US5254089A (en) | 1992-04-02 | 1993-10-19 | Boston Scientific Corp. | Medication dispensing balloon catheter |
US5368566A (en) | 1992-04-29 | 1994-11-29 | Cardiovascular Dynamics, Inc. | Delivery and temporary stent catheter having a reinforced perfusion lumen |
JPH05305146A (en) * | 1992-05-06 | 1993-11-19 | Sumitomo Bakelite Co Ltd | Medical balloon catheter |
US5269755A (en) | 1992-09-11 | 1993-12-14 | Sherwood Medical Company | Catheter with outer membrane medicament delivery system |
US5348538A (en) | 1992-09-29 | 1994-09-20 | Scimed Life Systems, Inc. | Shrinking balloon catheter having nonlinear or hybrid compliance curve |
US5500180A (en) | 1992-09-30 | 1996-03-19 | C. R. Bard, Inc. | Method of making a distensible dilatation balloon using a block copolymer |
US5279565A (en) | 1993-02-03 | 1994-01-18 | Localmed, Inc. | Intravascular treatment apparatus and method |
US5512051A (en) | 1993-02-16 | 1996-04-30 | Boston Scientific Corporation | Slip-layered catheter balloon |
US5456661A (en) | 1994-03-31 | 1995-10-10 | Pdt Cardiovascular | Catheter with thermally stable balloon |
US5415636A (en) | 1994-04-13 | 1995-05-16 | Schneider (Usa) Inc | Dilation-drug delivery catheter |
US5810767A (en) | 1994-05-11 | 1998-09-22 | Localmed, Inc. | Method and apparatus for pressurized intraluminal drug delivery |
US5499995C1 (en) | 1994-05-25 | 2002-03-12 | Paul S Teirstein | Body passageway closure apparatus and method of use |
US5514092A (en) | 1994-08-08 | 1996-05-07 | Schneider (Usa) Inc. | Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration |
US5891108A (en) | 1994-09-12 | 1999-04-06 | Cordis Corporation | Drug delivery stent |
DE69626635T2 (en) | 1995-03-31 | 2003-12-18 | Boston Scient Corp | BALLOON CATHETER WITH SEVERAL HOLES FOR DISPOSAL OF MEDICINAL PRODUCTS |
US5713853A (en) | 1995-06-07 | 1998-02-03 | Interventional Innovations Corporation | Methods for treating thrombosis |
US5752934A (en) | 1995-09-18 | 1998-05-19 | W. L. Gore & Associates, Inc. | Balloon catheter device |
US5868704A (en) | 1995-09-18 | 1999-02-09 | W. L. Gore & Associates, Inc. | Balloon catheter device |
US5827304A (en) | 1995-11-16 | 1998-10-27 | Applied Medical Resources Corporation | Intraluminal extraction catheter |
NL1002274C2 (en) | 1996-02-07 | 1997-08-08 | Cordis Europ | High-frequency thrombectomy catheter. |
WO1997031590A1 (en) | 1996-02-28 | 1997-09-04 | Impra, Inc. | Apparatus and method for making flanged graft for end-to-side anastomosis |
US5823996A (en) | 1996-02-29 | 1998-10-20 | Cordis Corporation | Infusion balloon catheter |
US5782797A (en) | 1996-06-06 | 1998-07-21 | Scimed Life Systems, Inc. | Therapeutic infusion device |
US5709653A (en) | 1996-07-25 | 1998-01-20 | Cordis Corporation | Photodynamic therapy balloon catheter with microporous membrane |
EP0835673A3 (en) | 1996-10-10 | 1998-09-23 | Schneider (Usa) Inc. | Catheter for tissue dilatation and drug delivery |
CA2273887A1 (en) | 1996-12-03 | 1998-06-25 | Atrium Medical Corporation | Multi-stage prosthesis |
US5868719A (en) | 1997-01-15 | 1999-02-09 | Boston Scientific Corporation | Drug delivery balloon catheter device |
US6203735B1 (en) | 1997-02-03 | 2001-03-20 | Impra, Inc. | Method of making expanded polytetrafluoroethylene products |
DE69828963T2 (en) | 1997-10-01 | 2006-01-26 | Medtronic AVE, Inc., Santa Rosa | Drug delivery and gene therapy delivery system |
US5948345A (en) * | 1998-01-05 | 1999-09-07 | Medtronic, Inc. | Method for making medical balloon catheter |
-
1999
- 1999-10-01 US US09/410,329 patent/US6395208B1/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040236308A1 (en) * | 2003-05-22 | 2004-11-25 | Atrium Medical Corp. | Kinetic isolation pressurization |
JP2019069003A (en) * | 2017-10-10 | 2019-05-09 | 株式会社ピーアールシー | Method and device for attaching balloon to catheter |
JP6994188B2 (en) | 2017-10-10 | 2022-01-14 | 株式会社ピーアールシー | How and equipment to attach a balloon to a catheter |
Also Published As
Publication number | Publication date |
---|---|
US6395208B1 (en) | 2002-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6395208B1 (en) | Method of making an expandable fluoropolymer device | |
US7740793B2 (en) | Expandable fluoropolymer device for delivery of therapeutic agents and method of making | |
US7637886B2 (en) | Expandable fluoropolymer device and method of making | |
EP1148899B1 (en) | Expandable fluoropolymer device for delivery of therapeutic agents | |
US5843116A (en) | Focalized intraluminal balloons | |
US6120523A (en) | Focalized intraluminal balloons | |
US5833657A (en) | Single-walled balloon catheter with non-linear compliance characteristic | |
EP0767684B1 (en) | Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith | |
JP5895017B2 (en) | Balloon catheter shaft having high strength and flexibility and manufacturing method thereof | |
US5411477A (en) | High-strength, thin-walled single piece catheters | |
US6004339A (en) | Balloon catheter with multiple distensibilities | |
US7906066B2 (en) | Method of making a balloon catheter shaft having high strength and flexibility | |
US5645560A (en) | Fixed focal balloon for interactive angioplasty and stent implantation | |
US20050121824A1 (en) | Method of making an expandable medical device formed of a compacted porous polymeric material | |
US6027486A (en) | Interactive angioplasty | |
EP0878209A2 (en) | A balloon for a dilation catheter and method for manufacturing a balloon | |
EP0410072A2 (en) | Apparatus and method for manufacturing balloons for medical devices | |
JPH0852219A (en) | Baloon catheter,multiple zone baloon catheter and method by using those | |
JP2006502799A (en) | Catheter balloon with advantageous cone design | |
JP2006502801A (en) | Expansion control type balloon | |
JPH0999087A (en) | Multilayer baloon that is installed in medical catheter, its manufacturing process and usage | |
US7448122B1 (en) | Method of compressing a polymeric layer of an expandable medical device | |
WO2019135741A1 (en) | Balloon with integral scoring element and related methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ATRIUM MEDICAL CORPORATION, NEW HAMPSHIRE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HERWECK, STEVE A.;GINGRAS, PETER H.;MARTAKOS, PAUL;AND OTHERS;REEL/FRAME:010376/0318;SIGNING DATES FROM 19991020 TO 19991026 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: RBS CITIZEN NATIONAL ASSOCIATION, NEW HAMPSHIRE Free format text: SECURITY AGREEMENT;ASSIGNOR:ATRIUM MEDICAL CORPORATION;REEL/FRAME:022610/0834 Effective date: 20090306 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 12 |